avex pharma semaglutide US FDA says lowest dose of Novo Nordisk's weight-loss drug now available Semaglutide | Wellnexa Health

When to reach out Persistent symptoms Contact the clinic if side effects are impacting your daily life

This might mean: Using medications strategically for specific tasks or times Combining lower medication doses with targeted supplements Integrating stress-reducing medications like Intuniv (guanfacine) that can help both attention and emotional regulation Creating medication-free days when appropriate Adjusting medication approaches as other supports take hold Heres how we think about different medication options and their integration with other therapies: Short-Acting Options (4-6 hours) Helpful for targeted coverage during specific tasks Allows for more flexibility in timing Can be useful for people who need coverage only during work hours Long-Acting Options (8-12 hours) Provides consistent coverage throughout the day Often helpful for emotional regulation as well as attention Can be easier to remember with once-daily dosing Intuniv (guanfacine) Helps with both attention and emotional regulation Particularly useful for managing stress response Can be combined with stimulants when needed Strattera (atomoxetine) Works 24/7 once built up in your system Often helpful for mood stability alongside attention Can be particularly useful for anxiety alongside ADHD We often find that thoughtful combinations work better than single medications alone: Combining long-acting and short-acting stimulants for customized coverage Using Intuniv alongside stimulants to reduce anxiety and improve emotional regulation Adding targeted supplements to enhance medication effectiveness Integrating stress-reduction techniques to improve medication response Medication is just one tool in our comprehensive approach

Eli Lilly, the company that makes Mounjaro and Zepbound (its brand names for tirzepatide), is developing one called orforglipron

The GIP receptor agonism complements GLP-1 receptor activation by enhancing glucose-dependent insulin secretion, thereby improving glycemic control and weight loss more effectively than GLP-1RAs alone